|
2022 Journal Article Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator eraDavidson, Sarah J., France, Megan, Callaway, Leonie K., Lust, Karin, Chambers, Daniel, Hopkins, Peter, Bell, Scott C., Burr, Lucy, Keating, Rebecca and Barrett, Helen L. (2022). Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era. Obstetric Medicine, 16 (4), 217-221. doi: 10.1177/1753495x221146342 |
|
2022 Journal Article The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness studyCox, Ingrid A., de Graaff, Barbara, Ahmed, Hasnat, Campbell, Julie, Otahal, Petr, Corte, Tamera J., Moodley, Yuben, Goh, Nicole, Hopkins, Peter, Macansh, Sacha, Walters, E. Haydn and Palmer, Andrew J. (2022). The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. European Journal of Health Economics, 24 (7), 1-19. doi: 10.1007/s10198-022-01538-7 |
|
2022 Journal Article Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed TomographyWalsh, Simon L. F., Mackintosh, John A., Calandriello, Lucio, Silva, Mario, Sverzellati, Nicola, Larici, Anna Rita, Humphries, Stephen M., Lynch, David A., Jo, Helen E., Glaspole, Ian, Grainge, Christopher, Goh, Nicole, Hopkins, Peter M. A., Moodley, Yuben, Reynolds, Paul N., Zappala, Christopher, Keir, Gregory, Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samantha, Wells, Athol U. and Corte, Tamera J. (2022). Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography. American Journal of Respiratory and Critical Care Medicine, 206 (7), 883-891. doi: 10.1164/rccm.202112-2684OC |
|
2022 Journal Article Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8DCox, Ingrid A., Campbell, Julie, de Graaff, Barbara, Otahal, Petr, Corte, Tamera J., Moodley, Yuben, Hopkins, Peter, Macansh, Sacha, Walters, E. Haydn and Palmer, Andrew J. (2022). Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D. Quality of Life Research, 32 (2), 1-21. doi: 10.1007/s11136-022-03205-z |
|
2022 Journal Article Markers of rejection of a lung allograft: state of the artSilva, Tharushi de, Voisey, Joanne, Hopkins, Peter, Apte, Simon, Chambers, Daniel and O'Sullivan, Brendan (2022). Markers of rejection of a lung allograft: state of the art. Biomarkers in Medicine, 16 (6), 483-498. doi: 10.2217/bmm-2021-1013 |
|
2022 Journal Article Biomarker signatures for progressive idiopathic pulmonary fibrosisClynick, Britt, Corte, Tamera J., Jo, Helen E., Stewart, Iain, Glaspole, Ian N., Grainge, Christopher, Maher, Toby M., Navaratnam, Vidya, Hubbard, Richard, Hopkins, Peter M. A., Reynolds, Paul N., Chapman, Sally, Zappala, Christopher, Keir, Gregory J., Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samantha, Goh, Nicole S., De Jong, Emma, Cha, Lilian, Tan, Dino B A, Leigh, Lucy, Oldmeadow, Christopher, Walters, E Haydn, Jenkins, R Gisli and Moodley, Yuben (2022). Biomarker signatures for progressive idiopathic pulmonary fibrosis. The European Respiratory Journal, 59 (3) 2101181, 1-12. doi: 10.1183/13993003.01181-2021 |
|
2022 Journal Article Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosisHumphries, Stephen M., Mackintosh, John A., Jo, Helen E., Walsh, Simon L. F., Silva, Mario, Calandriello, Lucio, Chapman, Sally, Ellis, Samantha, Glaspole, Ian, Goh, Nicole, Grainge, Christopher, Hopkins, Peter M. A., Keir, Gregory J., Moodley, Yuben, Reynolds, Paul N., Walters, E. Haydn, Baraghoshi, David, Wells, Athol U., Lynch, David A. and Corte, Tamera J. (2022). Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology, 27 (12), 1045-1053. doi: 10.1111/resp.14333 |
|
2021 Journal Article TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosisMacKintosh, John A., Pietsch, Maria, Lutzky, Viviana, Enever, Debra, Bancroft, Sandra, Apte, Simon H., Tan, Maxine, Yerkovich, Stephanie T., Dickinson, Joanne L., Pickett, Hilda A., Selvadurai, Hiran, Grainge, Christopher, Goh, Nicole S., Hopkins, Peter, Glaspole, Ian, Reynolds, Paul N., Wrobel, Jeremy, Jaffe, Adam, Corte, Tamera J. and Chambers, Daniel C. (2021). TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis. BMJ Open Respiratory Research, 8 (1) e001127, 1-8. doi: 10.1136/bmjresp-2021-001127 |
|
2021 Journal Article International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved documentMarczin, Nandor, de Waal, Eric E C, Hopkins, Peter M A, Mulligan, Michael S., Simon, Andre, Shaw, Andrew D., Van Raemdonck, Dirk, Neyrinck, Arne, Gries, Cynthia J., Algotsson, Lars, Szegedi, Laszlo and von Dossow, Vera (2021). International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. The Journal of Heart and Lung Transplantation, 40 (11), 1327-1348. doi: 10.1016/j.healun.2021.07.012 |
|
2021 Journal Article Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodiesDivithotawela, Chandima, Pham, Amy, Bell, Peter T., Ledger, Emma L., Tan, Maxine, Yerkovich, Stephanie, Grant, Michelle, Hopkins, Peter M., Wells, Timothy J. and Chambers, Daniel C. (2021). Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies. The Journal of Heart and Lung Transplantation, 40 (9), 951-959. doi: 10.1016/j.healun.2021.05.016 |
|
2021 Journal Article Combined heart-lung-liver transplantation for patients with cystic fibrosis: the Australian experienceBell, P. T., Carew, A., Fiene, A., Divithotawela, C., Stuart, K. A., Hodgkinson, P., Chambers, D. C. and Hopkins, P. M. (2021). Combined heart-lung-liver transplantation for patients with cystic fibrosis: the Australian experience. Transplantation Proceedings, 53 (7), 2382-2389. doi: 10.1016/j.transproceed.2021.07.028 |
|
2021 Journal Article Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation EnvironmentSeviiri, Mathias, Law, Matthew H., Ong, Jue Sheng, Gharahkhani, Puya, Nyholt, Dale R., Hopkins, Peter, Chambers, Daniel, Campbell, Scott, Isbel, Nicole M., Soyer, H. Peter, Olsen, Catherine M., Ellis, Jonathan J., Whiteman, David C., Green, Adele C. and MacGregor, Stuart (2021). Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment. Journal of Investigative Dermatology, 141 (12), 2866-2875.e2. doi: 10.1016/j.jid.2021.03.034 |
|
2021 Journal Article Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19Mackintosh, John A., Glenn, Laura, Barnes, Hayley, Dunn, Emily, Bancroft, Sandra, Reddy, Taryn, Teoh, Alan K. Y., Troy, Lauren, Jo, Helen, Geis, Monika, Glaspole, Ian, Grainge, Christopher, Corte, Tamera J., Chambers, Daniel C. and Hopkins, Peter (2021). Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19. Respirology, 26 (6), 612-615. doi: 10.1111/resp.14062 |
|
2021 Journal Article Airway Telomere Length in Lung Transplant RecipientsMackintosh, John A., Yerkovich, Stephanie T., Tan, Maxine E., Samson, Luke, Hopkins, Peter M.A. and Chambers, Daniel C. (2021). Airway Telomere Length in Lung Transplant Recipients. Frontiers in Immunology, 12 658062, 1-7. doi: 10.3389/fimmu.2021.658062 |
|
2021 Journal Article Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*Jee, Adelle S., Sheehy, Robert, Hopkins, Peter, Corte, Tamera J., Grainge, Christopher, Troy, Lauren K., Symons, Karen, Spencer, Lissa M., Reynolds, Paul N., Chapman, Sally, de Boer, Sally, Reddy, Taryn, Holland, Anne E., Chambers, Daniel C., Glaspole, Ian N., Jo, Helen E., Bleasel, Jane F., Wrobel, Jeremy P., Dowman, Leona, Parker, Matthew J.S., Wilsher, Margaret L., Goh, Nicole S.L., Moodley, Yuben and Keir, Gregory J. (2021). Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*. Respirology, 26 (1), 23-51. doi: 10.1111/resp.13977 |
|
2021 Journal Article The autotaxin-lysophosphatidic acid pathway mediates mesenchymal cell recruitment and fibrotic contraction in lung transplant fibrosisSinclair, Kenneth Andrew, Yerkovich, Stephanie Terase, Hopkins, Peter Mark-Anthony, Fieuw, Ann M., Ford, Paul, Powell, Joseph Edwin, O'Sullivan, Brendan and Chambers, Daniel Charles (2021). The autotaxin-lysophosphatidic acid pathway mediates mesenchymal cell recruitment and fibrotic contraction in lung transplant fibrosis. Journal of Heart and Lung Transplantation, 40 (1), 12-23. doi: 10.1016/j.healun.2020.10.005 |
|
2021 Journal Article Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in AustraliaCox, Ingrid A., Otahal, Petr, de Graaff, Barbara, Corte, Tamera J., Moodley, Yuben, Zappala, Chris, Glaspole, Ian, Hopkins, Peter, Macansh, Sacha, Walters, E. Haydn and Palmer, Andrew J. (2021). Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia. Respirology, 27 (3), 209-216. doi: 10.1111/resp.14194 |
|
2020 Journal Article Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort studyAltaf, Mohammed, Lineburg, Katie E., Crooks, Pauline, Rehan, Sweera, Matthews, Katherine K., Neller, Michelle A, Ambalathingal, George R., Sinha, Debottam, Grant, Michelle, Hopkins, Peter M. A., Chambers, Daniel, Khanna, Rajiv and Smith, Corey (2020). Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study. The Journal of infectious diseases, 224 (2), 312-317. doi: 10.1093/infdis/jiaa750 |
|
2020 Journal Article Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: Case-control studyAbramson, Michael J., Murambadoro, Tsitsi, Alif, Sheikh M., Benke, Geza P., Dharmage, Shyamali C., Glaspole, Ian, Hopkins, Peter, Hoy, Ryan F., Klebe, Sonja, Moodley, Yuben, Rawson, Shuli, Reynolds, Paul N., Wolfe, Rory, Corte, Tamera J. and Haydn Walters, E. (2020). Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: Case-control study. Thorax, 75 (10), 864-869. doi: 10.1136/thoraxjnl-2019-214478 |
|
2020 Journal Article Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancerGreen, Adele C., Way, Mandy, Oster, Mariella, Plasmeijer, Elsemieke I., Jiyad, Zainab, O’Rourke, Peter, Miura, Kyoko, Campbell, Scott, Isbel, Nicole, Chambers, Daniel C., Hopkins, Peter, Ferguson, Lisa E., Davis, Marcia Batista, Whiteman, David C., Soyer, H. Peter and Marquart, Louise (2020). Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer. Archives of Dermatological Research, 314 (2), 203-206. doi: 10.1007/s00403-020-02136-4 |
